Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Beckman Coulter; CLC Bio; BGI, GT Life Sciences; Massachusetts Life Sciences Center

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The auction progress to determine who will be come the buyer of Beckman Coulter has reached a second round, according to a report from Reuters this week. According to the news organization, private equity firms have paired up in an effort to provide a winning bid, while a source said that Danaher is among the bidders.

Beckman also cancelled its scheduled presentation at the JP Morgan Healthcare Conference next week.

Reports surfaced early in December that Beckman had put itself up for sale and could fetch more than $5 billion in a deal.

CLC Bio said this week that its 2010 sales increased 64 percent year over year, though it did not disclose any details or further financial information. It noted that its 2009 sales were above $10 million for the first time.

BGI and GT Life Sciences this week said that they have completed for the first time the sequencing of the Chinese hamster ovary genome, which they believe will provide useful information that could potentially cut the cost of producing therapeutic proteins. Early access to the genome is available through BGI.

The Massachusetts Life Sciences Center said this week that it has opened the application period for the second year of its Small Business Matching Grant Program, which provides grant funding to match federal small business grants for early-stage life sciences companies in the state. MLSC said that it will make $3 million available for the program in this round.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.